|
US6407061B1
(en)
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
|
WO1991007947A1
(en)
|
1989-12-05 |
1991-06-13 |
Ramsey Foundation |
Neurologic agents for nasal administration to the brain
|
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
|
AU649897B2
(en)
|
1991-11-14 |
1994-06-02 |
Women's And Children's Hospital |
Synthetic alpha-L-iduronidase and genetic sequences encoding same
|
|
FR2716893B1
(fr)
|
1994-03-03 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Virus recombinants, leur préparation et leur utilisation thérapeutique.
|
|
US6190659B1
(en)
|
1996-09-17 |
2001-02-20 |
The Rockefeller University |
Bacterial plasmin binding protein and methods of use thereof
|
|
AU8672198A
(en)
|
1997-07-31 |
1999-02-22 |
Chiron Corporation |
Method enabling readministration of aav vector via immunosuppression of host
|
|
DE69929600T2
(de)
|
1998-05-27 |
2006-09-07 |
Avigen Inc., Alameda |
Konvektion-erhöhte verabreichung aadc-kodierende aav vektoren
|
|
US7273618B2
(en)
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
|
ES2252993T3
(es)
|
1998-12-09 |
2006-05-16 |
Chiron Corporation |
Administracion de agentes neurotroficos al sistema nervioso central.
|
|
AU2173400A
(en)
|
1998-12-09 |
2000-06-26 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
|
PT1916258E
(pt)
|
1999-08-09 |
2014-07-29 |
Genzyme Corp |
Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
|
|
US6426208B1
(en)
|
1999-11-12 |
2002-07-30 |
Harbor-Ucla Research And Education Institute |
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
US6585971B1
(en)
|
1999-11-12 |
2003-07-01 |
Harbor-Ucla Research And Education Institute |
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
|
|
US6569661B1
(en)
|
1999-11-12 |
2003-05-27 |
Biomarin Pharmaceutical Inc. |
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
AU1775901A
(en)
|
1999-11-17 |
2001-05-30 |
Avigen, Inc. |
Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
|
|
EP1237567B1
(en)
|
1999-12-09 |
2005-08-03 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
|
US7084126B1
(en)
|
2000-05-01 |
2006-08-01 |
Healthpartners Research Foundation |
Methods and compositions for enhancing cellular function through protection of tissue components
|
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
AU2001267337A1
(en)
|
2000-06-30 |
2002-01-14 |
Maxygen Aps |
Peptide extended glycosylated polypeptides
|
|
AU7194101A
(en)
|
2000-07-18 |
2002-01-30 |
Univ Duke |
Treatment of glycogen storage disease type ii
|
|
US20020014242A1
(en)
|
2000-07-31 |
2002-02-07 |
Abraham Scaria |
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
|
|
EP1370282A2
(en)
|
2000-10-13 |
2003-12-17 |
Chiron Corporation |
Method for treating ischemic events affecting the central nervous system
|
|
US20020169102A1
(en)
|
2001-04-03 |
2002-11-14 |
Frey William H. |
Intranasal delivery of agents for regulating development of implanted cells in the CNS
|
|
WO2002086105A1
(en)
|
2001-04-20 |
2002-10-31 |
Chiron Corporation |
Delivery of polynucleotide agents to the central nervous sysstem
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
EP1487474A4
(en)
|
2002-02-25 |
2006-11-29 |
Chiron Corp |
INTRANASAL ADMINISTRATION OF MC4-R AGONISTS
|
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
AU2003302724A1
(en)
|
2002-08-13 |
2004-07-09 |
Mcivor, Scott, R. |
Methods of using vectors to treat metabolic disorders
|
|
AU2003272728A1
(en)
|
2002-09-27 |
2004-04-19 |
Children's Medical Center Corporation |
Methods and compositions for treatment of neurological disorder
|
|
US8512710B2
(en)
|
2002-11-22 |
2013-08-20 |
Ansun Biopharma, Inc. |
Class of therapeutic protein based molecules
|
|
US7446098B2
(en)
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
|
EP1618201A1
(en)
|
2003-05-01 |
2006-01-25 |
University of Florida Research Foundation, Inc. |
Vp2 - modified raav vectors and uses thereof
|
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
|
US7442372B2
(en)
|
2003-08-29 |
2008-10-28 |
Biomarin Pharmaceutical Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
WO2005062881A2
(en)
|
2003-12-24 |
2005-07-14 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
|
US7618615B2
(en)
|
2004-08-13 |
2009-11-17 |
Healthpartners Research Foundation |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
|
US7776312B2
(en)
|
2004-08-13 |
2010-08-17 |
Healthpartners Research Foundation |
Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
|
|
US20090136505A1
(en)
|
2005-02-23 |
2009-05-28 |
Johanna Bentz |
Intranasal Administration of Active Agents to the Central Nervous System
|
|
NZ581205A
(en)
|
2005-02-23 |
2011-06-30 |
Alza Corp |
Intranasal administration of active agents to the central nervous system
|
|
WO2006110689A2
(en)
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
EP1777906A1
(en)
|
2005-06-09 |
2007-04-25 |
Matsushita Electric Industrial Co., Ltd. |
Amplitude error compensating apparatus and orthogonality error compensating apparatus
|
|
CA2620202C
(en)
|
2005-08-26 |
2016-10-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapy procedure for drug delivery for trigeminal pain
|
|
JP5706602B2
(ja)
|
2006-02-08 |
2015-04-22 |
ジェンザイム・コーポレーション |
ニーマンピック病ａ型に対する遺伝子治療
|
|
DK1988823T3
(en)
|
2006-02-09 |
2018-12-03 |
Genzyme Corp |
SLOW INTRAVENTRICULAR ADMINISTRATION
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
WO2007127163A2
(en)
|
2006-04-24 |
2007-11-08 |
Geron Corporation |
Cns-tumor treatment method and composition
|
|
EP1915986A1
(en)
|
2006-10-23 |
2008-04-30 |
BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH |
Lipid growth factor formulations
|
|
US20120322861A1
(en)
|
2007-02-23 |
2012-12-20 |
Barry John Byrne |
Compositions and Methods for Treating Diseases
|
|
EP2132309A4
(en)
|
2007-02-23 |
2011-01-05 |
Univ Florida |
COMPOSITIONS AND METHODS OF TREATING GLYCOLOGICAL MEMORY DISEASES
|
|
PL3252161T3
(pl)
|
2007-06-06 |
2022-03-07 |
Genzyme Corporation |
Terapia genowa dla lizosomalnych chorób spichrzeniowych
|
|
EP2152240A4
(en)
|
2007-06-08 |
2012-05-09 |
Healthpartners Res Foundation |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM
|
|
US8283160B2
(en)
|
2007-09-11 |
2012-10-09 |
Frey Ii William H |
Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
WO2009075815A1
(en)
|
2007-12-07 |
2009-06-18 |
Duke University |
Immunomodulating gene therapy
|
|
DK2242840T3
(da)
|
2008-01-29 |
2019-10-21 |
Applied Genetic Tech Corporation |
Produktion af rekombinant adeno-associeret virus under anvendelse af bhk-celler i suspension
|
|
WO2009120978A2
(en)
|
2008-03-27 |
2009-10-01 |
The Ohio State University |
Treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therfor
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
US11219696B2
(en)
|
2008-12-19 |
2022-01-11 |
Nationwide Children's Hospital |
Delivery of polynucleotides using recombinant AAV9
|
|
US9415121B2
(en)
|
2008-12-19 |
2016-08-16 |
Nationwide Children's Hospital |
Delivery of MECP2 polynucleotide using recombinant AAV9
|
|
WO2010071832A1
(en)
|
2008-12-19 |
2010-06-24 |
Nationwide Children's Hospital |
Delivery of polynucleotides across the blood brain barrier using recombinant aav9
|
|
US7989502B2
(en)
|
2009-02-06 |
2011-08-02 |
Sri International |
Intranasal delivery of modafinil
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
US20110070241A1
(en)
|
2009-06-30 |
2011-03-24 |
Duke University |
Methods for modulating immune responses to aav gene therapy vectors
|
|
US8622993B2
(en)
|
2009-12-18 |
2014-01-07 |
Healthpartners Research Foundation |
Device and method for delivering therapeutic substances to the maxillary sinus of a patient
|
|
CN102791130B
(zh)
*
|
2010-03-03 |
2015-02-25 |
泰华制药工业有限公司 |
使用拉喹莫德治疗狼疮肾炎
|
|
US20130023033A1
(en)
|
2010-03-29 |
2013-01-24 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
EP2826860B1
(en)
|
2010-04-23 |
2018-08-22 |
University of Massachusetts |
CNS targeting AAV vectors and methods of use thereof
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
EP2394667A1
(en)
|
2010-06-10 |
2011-12-14 |
Laboratorios Del Dr. Esteve, S.A. |
Vectors and sequences for the treatment of diseases
|
|
NZ605873A
(en)
|
2010-06-25 |
2015-02-27 |
Shire Human Genetic Therapies |
Methods and compositions for cns delivery of arylsulfatase a
|
|
NZ605874A
(en)
|
2010-06-25 |
2015-02-27 |
Shire Human Genetic Therapies |
Methods and compositions for cns delivery of heparan n-sulfatase
|
|
CN103179980B
(zh)
|
2010-06-25 |
2016-09-28 |
夏尔人类遗传性治疗公司 |
艾杜糖醛酸-2-硫酸酯酶的cns递送的方法和组合物
|
|
RS62620B1
(sr)
|
2010-06-25 |
2021-12-31 |
Shire Human Genetic Therapies |
Metode i kompozicije za isporuku cns akrilsulfataze a
|
|
SMT201600385T1
(it)
|
2010-06-25 |
2017-03-08 |
Shire Human Genetic Therapies |
Trasporto di agenti terapeutici all’snc
|
|
WO2012101671A1
(en)
|
2011-01-25 |
2012-08-02 |
Jcr Pharmaceuticals Co., Ltd. |
Method for production of human recombinant iduronate 2-sulfatase
|
|
WO2012109570A1
(en)
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
DK2675902T3
(da)
|
2011-02-17 |
2019-06-03 |
Univ Pennsylvania |
Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
|
|
ES2745470T3
(es)
|
2011-03-31 |
2020-03-02 |
Univ Iowa Res Found |
Partícula de AAV2 que comprende una proteína de la cápside de AAV2 y un vector que comprende un ácido nucleico que codifica una tripeptidilo peptidasa 1 (TPP1) para el tratamiento de lipofuscinosis ceroide infantil tardía (LINCL) en un mamífero no roedor mediante inyección intraventricular o administración icv
|
|
ES2702496T3
(es)
|
2011-04-21 |
2019-03-01 |
Nationwide Childrens Hospital Inc |
Productos de virus recombinante y procedimientos para la inhibición de la expresión de la miotilina
|
|
US10196636B2
(en)
|
2011-04-21 |
2019-02-05 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of myotilin
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
EP2709670A4
(en)
|
2011-05-18 |
2015-01-21 |
Childrens Hosp Medical Center |
TARGETED TRANSFER OF PROTEINS OVER THE BLOOD BRAIN BARRIER
|
|
US20130039888A1
(en)
|
2011-06-08 |
2013-02-14 |
Nationwide Children's Hospital Inc. |
Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
|
|
US9387236B2
(en)
|
2011-06-10 |
2016-07-12 |
Prothera Inc. |
Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
|
|
AU2012286994B2
(en)
|
2011-07-25 |
2017-08-10 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of DUX4
|
|
JP6329483B2
(ja)
|
2011-10-12 |
2018-05-23 |
シナジェバ・バイオファーマ・コーポレイションＳｙｎａｇｅｖａ Ｂｉｏｐｈａｒｍａ Ｃｏｒｐ． |
組換えヒトｎａｇｌｕタンパク質およびその利用
|
|
US9821149B2
(en)
|
2011-10-14 |
2017-11-21 |
Healthpartners Research & Education |
Methods for using ultrasound for enhancing efficiency and targeting of intranasal administration of therapeutic compounds to the central nervous system
|
|
JP6188703B2
(ja)
|
2011-10-27 |
2017-08-30 |
サンガモ セラピューティクス， インコーポレイテッド |
Ｈｐｒｔ遺伝子座を修飾するための方法および組成物
|
|
AU2012346448B2
(en)
|
2011-12-02 |
2017-09-14 |
Armagen, Inc. |
Methods and compositions for increasing arylsulfatase A activity in the CNS
|
|
CA2863964C
(en)
|
2012-02-07 |
2021-10-26 |
Global Bio Therapeutics Usa, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
|
CN104203120A
(zh)
|
2012-03-23 |
2014-12-10 |
泰尔茂株式会社 |
穿刺器具以及穿刺装置
|
|
RS61055B1
(sr)
|
2012-06-19 |
2020-12-31 |
Univ Florida |
Kompozicije i postupci za lečenje bolesti
|
|
WO2013190059A1
(en)
|
2012-06-21 |
2013-12-27 |
Association Institut De Myologie |
Widespread gene delivery of gene therapy vectors
|
|
AU2013296425B2
(en)
|
2012-08-01 |
2018-06-07 |
Nationwide Children's Hospital |
Intrathecal delivery of recombinant adeno-associated virus 9
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
HUE039334T2
(hu)
|
2012-11-27 |
2018-12-28 |
Biomarin Pharm Inc |
Célzott terápiás lizoszómális enzim fúziós fehérjék és azok alkalmazásai
|
|
WO2014125647A1
(ja)
|
2013-02-18 |
2014-08-21 |
富士通オプティカルコンポーネンツ株式会社 |
光受信装置
|
|
SI2984166T1
(sl)
|
2013-03-15 |
2020-09-30 |
The Trustees Of The University Of Pennsylvania |
Sestavki za zdravljenje MPSI
|
|
KR102413498B1
(ko)
|
2013-04-20 |
2022-06-24 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
엑손 2-표적 U7snRNA 폴리뉴클레오티드 작제물의 재조합형 아데노 부속 바이러스 전달
|
|
MX380973B
(es)
|
2013-05-01 |
2025-03-12 |
Genzyme Corp |
Composiciones y metodos para tratar la atrofia muscular espinal.
|
|
CN105377039A
(zh)
|
2013-05-15 |
2016-03-02 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
EP3024497B1
(en)
|
2013-07-26 |
2021-01-13 |
University of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
WO2015021443A1
(en)
|
2013-08-08 |
2015-02-12 |
Global Bio Therapeutics Usa, Inc. |
Clamp device for minimally invasive procedures and uses thereof
|
|
LT3702466T
(lt)
|
2013-08-27 |
2023-02-27 |
Research Institute At Nationwide Children's Hospital |
Produktai ir būdai, skirti šoninės amiotrofinės sklerozės gydymui
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
CN120174012A
(zh)
|
2013-10-24 |
2025-06-20 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
US20170049887A1
(en)
|
2014-04-25 |
2017-02-23 |
University Of Florida Research Foundation, Inc. |
Methods of permitting a subject to receive multiple doses of recombinant adeno-associated virus
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
BR112017005892A2
(pt)
|
2014-09-24 |
2017-12-12 |
Hope City |
variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
CN107249646B
(zh)
|
2014-12-16 |
2021-06-29 |
内布拉斯加大学董事会 |
用于青少年巴滕病的基因疗法
|
|
US10538589B2
(en)
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
|
HK1256341A1
(zh)
|
2015-05-15 |
2019-09-20 |
明尼苏达大学董事会 |
用於治疗性递送到中枢神经系统的腺相关物
|
|
EP3101125A1
(en)
|
2015-06-05 |
2016-12-07 |
Laboratorios Del Dr. Esteve, S.A. |
Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
|
|
EP3322297B1
(en)
|
2015-07-13 |
2024-12-04 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
HK1257801A1
(zh)
*
|
2015-10-28 |
2019-11-01 |
宾夕法尼亚州大学信托人 |
用於基因治疗的腺伴随病毒载体的鞘内给药
|
|
CA3010738A1
(en)
|
2016-01-15 |
2017-07-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of neurologic disease
|
|
EP3411488A1
(en)
*
|
2016-02-03 |
2018-12-12 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type i
|
|
PL3411484T3
(pl)
|
2016-02-05 |
2024-02-19 |
Emory University |
Wstrzykiwanie jednoniciowego lub samokomplementarnego wirusa adenosatelitarnego 9 do płynu mózgowego
|
|
US10561894B2
(en)
|
2016-03-18 |
2020-02-18 |
Icon Health & Fitness, Inc. |
Treadmill with removable supports
|
|
IL305449B2
(en)
*
|
2016-04-15 |
2026-01-01 |
Univ Pennsylvania |
Gene therapy for the treatment of mucocutaneous type ii diabetes
|
|
EP3541946A1
(en)
|
2016-11-15 |
2019-09-25 |
Regents Of The University Of Minnesota |
Method for improving neurological function in mpsi and mpsii and other neurological disorders
|
|
CA3049915A1
(en)
|
2017-01-31 |
2018-08-09 |
Stephen YOO |
Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)
|
|
KR102719222B1
(ko)
|
2017-05-11 |
2024-10-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
신경 세로이드 지질갈색소증에 대한 유전자 요법
|
|
MA50016A
(fr)
|
2017-07-06 |
2020-07-08 |
Univ Pennsylvania |
Thérapie génique médiée par aav9 pour traiter la mucopolysaccharidose de type i
|
|
TWI835747B
(zh)
|
2017-09-22 |
2024-03-21 |
賓州大學委員會 |
用於治療黏多醣病 ii 型之基因治療
|
|
IL280198B2
(en)
|
2018-07-18 |
2026-01-01 |
Regenxbio Inc |
Treatment of mucopolysaccharidosis I with fully glycosylated human iduronidase-alpha-L (idus)
|
|
US20240084917A1
(en)
|
2019-10-07 |
2024-03-14 |
Wartsila Services Switzerland Ltd. |
Step lift control of hydraulically actuated popped valves
|
|
WO2021150570A1
(en)
|
2020-01-22 |
2021-07-29 |
Regenxbio Inc. |
Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)
|